Optimization of the Tet-On system for regulated gene expression through viral evolution

The ability to control (trans)gene expression is important both for basic biological research and applications such as gene therapy. In vivo use of the inducible tetracycline (Tc)-regulated gene expression system (Tet-On system) is limited by its low sensitivity for the effector doxycycline (dox). We used viral evolution to optimize this Escherichia coli-derived regulatory system for its function in mammalian cells. The components of the Tet-On system (the transcriptional activator rtTA and its tetO DNA binding site) were incorporated into the human immunodeficiency virus (HIV)-1 genome to control viral replication. Prolonged culturing of this HIV-rtTA virus resulted in virus variants that acquired mutations in the rtTA gene. Some of these mutations enhance the transcriptional activity and dox-sensitivity of the rtTA protein. This improvement was observed with different tetO-containing promoters and was independent of the episomal or chromosomal status of the target gene. Combination of these beneficial mutations resulted in greatly improved rtTA variants that are seven-fold more active and 100-fold more dox-sensitive than the original Tet-On system. Furthermore, some of the new Tet-On systems are responsive to Tc and minocycline. Importantly, these rtTA variants show no activity in the absence of dox. The optimized rtTA variants are particularly useful for in vivo applications that require a more sensitive or more active Tet-On system.

[1]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[2]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[3]  K. Jeang,et al.  Constitutively Dead, Conditionally Live HIV-1 Genomes , 2001, The Journal of Biological Chemistry.

[4]  A. Das,et al.  Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine , 2002, Expert review of vaccines.

[5]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Das,et al.  Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine. , 2002, Journal of neurovirology.

[7]  Wolfgang Hillen,et al.  Gene regulation by tetracyclines. , 2004, Genetic engineering.

[8]  W. Hillen,et al.  Single-chain Tet transregulators. , 2003, Nucleic acids research.

[9]  I. Mikaélian,et al.  A general and fast method to generate multiple site directed mutations. , 1992, Nucleic acids research.

[10]  M. Gossen,et al.  Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Warnke,et al.  Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. , 1984, Cancer research.

[12]  J. Mallet,et al.  A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. , 2004, Human gene therapy.

[13]  A. Das,et al.  A Hairpin Structure in the R Region of the Human Immunodeficiency Virus Type 1 RNA Genome Is Instrumental in Polyadenylation Site Selection , 1999, Journal of Virology.

[14]  Ben Berkhout,et al.  Efficient Human Immunodeficiency Virus Replication Requires a Fine-Tuned Level of Transcription , 2002, Journal of Virology.

[15]  B. Berkhout,et al.  In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Bujard,et al.  Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. , 2000, Methods in enzymology.

[17]  R. Hawkins,et al.  Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues , 1997, Gene Therapy.

[18]  B. Berkhout,et al.  Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat , 2001, Journal of Virology.

[19]  H. Mizuguchi,et al.  The tet‐off system is more effective than the tet‐on system for regulating transgene expression in a single adenovirus vector , 2002, The journal of gene medicine.

[20]  A. Das,et al.  A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication , 1997, Journal of virology.

[21]  W. Hillen,et al.  Structure-based design of Tet repressor to optimize a new inducer specificity. , 2004, Biochemistry.

[22]  A. Das,et al.  A conditionally replicating virus as a novel approach toward an HIV vaccine. , 2004, Methods in enzymology.

[23]  W. Saenger,et al.  Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. , 1994, Science.

[24]  M. Fussenegger,et al.  The Impact of Mammalian Gene Regulation Concepts on Functional Genomic Research, Metabolic Engineering, and Advanced Gene Therapies , 2001, Biotechnology progress.

[25]  W. Hillen,et al.  Tetracyclines in Biology, Chemistry and Medicine , 2001, Birkhäuser Basel.

[26]  M. Gossen,et al.  Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. , 1997, Nucleic acids research.

[27]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[28]  W. Hillen,et al.  Mechanism of Tet repressor induction by tetracyclines: length compensates for sequence in the alpha8-alpha9 loop. , 2001, Journal of molecular biology.

[29]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  W. Saenger,et al.  The complex formed between Tet repressor and tetracycline-Mg2+ reveals mechanism of antibiotic resistance. , 1995 .

[31]  W. Hillen,et al.  Identification of a stability determinant on the edge of the Tet repressor four-helix bundle dimerization motif. , 2001, Biochemistry.

[32]  A. Das,et al.  Viral Evolution as a Tool to Improve the Tetracycline-regulated Gene Expression System* , 2004, Journal of Biological Chemistry.

[33]  W. Saenger,et al.  Structural basis of gene regulation by the tetracycline inducible Tet repressor–operator system , 2000, Nature Structural Biology.

[34]  F. Cordes,et al.  Conformational changes of the Tet repressor induced by tetracycline trapping. , 1998, Journal of molecular biology.

[35]  W. Hillen,et al.  Gene regulation by tetracyclines. Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes. , 2003, European journal of biochemistry.

[36]  W. Saenger,et al.  Characterization of non-inducible Tet repressor mutants suggests conformational changes necessary for induction , 1995, Nature Structural Biology.

[37]  N. Auersperg.  LONG-TERM CULTIVATION OF HYPODIPLOID HUMAN TUMOR CELLS. , 1964, Journal of the National Cancer Institute.

[38]  J. Ruijter,et al.  Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology , 2006, Retrovirology.

[39]  M. Gossen,et al.  Tetracyclines in the control of gene expression in eukaryotes , 2001 .